Autoimmune-mediated destruction of ?-cells is the predominant cause of Type 1 diabetes mellitus (T1 DM). Current therapy, based on the replacement of ?-cells through islet transplantation and subsequent immune suppression, has significant limitations. In this proposal we focus on the natural ability of ?-cells to regenerate and restore glucose homeostasis in a mouse model of diabetes. The long-term goal of this project is to utilize the natural ability of ?-cells to regenerate as an innovative approach for the treatment of T1DM. This project represents a continuation of collaborative studies between the Chong, Philipson and Fu laboratories. Little is known about the capacity of regenerated islets to reproduce the normal physiological function of ?-cells and maintain glucose homeostasis after the development of overt diabetes. We have developed a new model of islet regeneration that will enable us to systematically define key mechanisms in ?-cell restoration. Our preliminary experiments demonstrate restoration of functional ?-cell mass and blood glucose regulation following an induced destruction of adult mouse ?-cells with high-dose streptozotocin (STZ). We also observed a significant requirement for splenocytes in islet cell regeneration after high-dose STZ treatment. ? ? The cellular and molecular basis for how splenocytes enhance ?-cell regeneration is not known. Published results have suggested that the signals triggering liver regeneration also trigger ?-cell proliferation and regeneration. Recent studies by Fu laboratory have revealed a novel role of T lymphocytes and lymphotoxin-? (LT?) signaling in facilitating liver regeneration. In this proposal, we will test the overall hypothesis that the cellular and soluble or cell membrane factors stimulating liver regeneration also stimulate ?-cell regeneration.
The Specific Aims are to:
Specific Aim 1. Test the hypothesis that T lymphocytes are the critical cell subset in the spleen regulating the regeneration of ? ?-cells in vivo. We will compare the rate of ?-cell regeneration in C57BL/6 mice lacking T cells, and made diabetic with STZ. We will also test whether splenocytes depleted of T cells have reduced efficacy in stimulating ?-cell regeneration in splenectomized, diabetic mice.
Specific Aim 2. Test the hypothesis that lymphotoxin-beta receptor (LT?R) signaling plays a critical role in stimulating ?-cell regeneration in vivo. We will test whether the rate of ?-cell regeneration is reduced when signaling through the LT?R is prevented by soluble LT?R (sLT?R) or in LT?R deficient mice. We will also test whether expression of the ligands of LT?R, LTa? or LIGHT, on spleen cells and LT?R on islet ?-cells is critical for stimulating ?-cell regeneration. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21DK073529-02
Application #
7229854
Study Section
Cellular Aspects of Diabetes and Obesity Study Section (CADO)
Program Officer
Sato, Sheryl M
Project Start
2006-02-15
Project End
2009-01-31
Budget Start
2007-02-01
Budget End
2009-01-31
Support Year
2
Fiscal Year
2007
Total Cost
$223,573
Indirect Cost
Name
University of Chicago
Department
Surgery
Type
Schools of Medicine
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Grossman, Eric J; Lee, David D; Tao, Jing et al. (2010) Glycemic control promotes pancreatic beta-cell regeneration in streptozotocin-induced diabetic mice. PLoS One 5:e8749
Ma, Lianli; Xiang, Zhidan; Sherrill, Taylor P et al. (2008) Bioluminescence imaging visualizes activation of nuclear factor-kappaB in mouse cardiac transplantation. Transplantation 85:903-10
Alegre, Maria-Luisa; Goldstein, Daniel R; Chong, Anita S (2008) Toll-like receptor signaling in transplantation. Curr Opin Organ Transplant 13:358-65
Lee, D D; Grossman, E; Chong, A S (2008) Cellular therapies for type 1 diabetes. Horm Metab Res 40:147-54
Wang, Tongmin; Chen, Luqiu; Ahmed, Emily et al. (2008) Prevention of allograft tolerance by bacterial infection with Listeria monocytogenes. J Immunol 180:5991-9
Li, Yijin; Ma, Lianli; Yin, Dengping et al. (2008) Long-term control of alloreactive B cell responses by the suppression of T cell help. J Immunol 180:6077-84
Xiang, Zhidan; Ma, Lian-Li; Manicassamy, Santhakumar et al. (2008) CD4+ T cells are sufficient to elicit allograft rejection and major histocompatibility complex class I molecule is required to induce recurrent autoimmune diabetes after pancreas transplantation in mice. Transplantation 85:1205-11
Yin, Dengping; Tao, Jing; Lee, David D et al. (2006) Recovery of islet beta-cell function in streptozotocin- induced diabetic mice: an indirect role for the spleen. Diabetes 55:3256-63